OUR JOURNAL POLICY ON ETHICAL PRINCIPLES AND RESEARCH PUBLICATION ETHICS;
ETHICAL PRINCIPLES
The recommendations of ICMJE (International Committee of Medical Journal Editors) and the International Standards for Editors and Authors of COPE (Committee on Publication Ethics) should be taken into consideration in scientific manuscripts submitted to the journal.
RESEARCH PUBLICATION ETHICS
1-Studies requiring Ethics Committee approval (studies requiring questionnaire or scale application, including interviews and observations; documents, pictures, questionnaires, etc. developed by others and requiring permission for use) (For research conducted in all branches of science, including social sciences, and for clinical and experimental human and animal studies requiring ethics committee approval, separate ethics committee approval must be obtained, this approval must be specified and documented in the article.), the necessary permissions from ethics committees or commissions must be obtained before the research is carried out, and these must be specified in the article content or presented as an attachment. In the absence of these permissions, the publication will be returned to the author at the preliminary review stage.
2- In studies requiring ETHICAL COMMITTEE PERMISSION, information about the permission (name of the committee, date and number) should be included on the FIRST page of the article and at the BOTTOM of the page. In addition, in case presentations, information on the signature of the informed consent/assent form must be included in the method section of the article. The responsibility for these belongs to the author. If the permissions requested in applied research are not submitted, the article will be returned without evaluation.
3-Copyright regulations must be complied with for the intellectual and artistic works used.
4-Raw data related to the researches in the referee evaluations must be submitted when requested by the referees. It is obligatory to provide the data as necessary after the publication of the article.
Ethical Rules for Authors
Authors guarantee that their work is original and when they include ideas, language, pictures, graphics and tables of other researchers in their work, they must indicate this as a citation. Quoting without acknowledging the source is plagiarism.
Each author mentioned in the study is equally responsible for the content of the study. It is unacceptable that the researcher's name is not included in the study even though he/she has contributed to the study or that his/her name is unfairly included even though he/she has not contributed to the study.
Authors should remain faithful to the findings of their research. It is out of question to change the findings, to fabricate findings and results, and to conduct research based on them. Tampering with data and materials, deleting, omitting, or skipping the interpretation of difficult to handle data is a breach of trust.
Simultaneous submission of the work to journals is out of the question. Authors cannot submit their previously published works to the journal.
Ethical Rules for Reviewers
Reviewers should be aware that the evaluation process is confidential and should not be shared with external third parties.
Reviewers should submit an objective, impartial, scientific, clear and constructive evaluation report on the manuscript within the specified time limit.
Referee reports will also include an evaluation of the scientific quality of the article (the topic addressed, the methodology used, or the appropriate use of relevant literature). This evaluation, whether positive or negative, must be made about the content.
Referees should notify the editor if it is found that the manuscript has been plagiarised or has been previously published elsewhere.
OUR JOURNAL POLICY ON CO-AUTHORSHIP
The studies to be included in our journal may be prepared by one or more authors. In studies with more than one author, the authors' names should be ranked according to their contributions to the study and the “Copyright transfer form” should have the wet signatures of all authors and these signatures should be according to the order of authors in the study. The Copyright Transfer form will be requested later from the authors of the articles that are decided to be published. When submitting an article, do not send it.
ETHICS COMMITTEE APPROVAL
In line with ULAKBIM 2020 criteria, ethics committee approval must be obtained for clinical and experimental human and animal research in all fields, including Social Sciences, and this approval must be stated and documented in the article. The name, date and number of the ethics committee approval should be included on the first page and at the bottom of the article.
Studies requiring ethics committee approval are listed below:
1. Any qualitative or quantitative research in which interview, focus group study, observation, experiment, survey and interview techniques are used and data are collected accordingly,
2. The use of humans or animals for experimental and other scientific purposes,
3. Clinical research on humans and animals,
4. Retrospective studies in accordance with the personal data protection law.
In case reports submitted to the journal, it is important to include information that the voluntary consent/assent form has been signed.
Studies that do not require Ethics Committee Approval:
In studies conducted before 2020 with data obtained before 2020 (the date of data collection should be given in the method section), in studies obtained from master's / doctoral studies with data collected before 2020 (should be specified as a footnote), in paper studies with data collected and presented before 2020 (should be specified as a footnote), in studies submitted to the journal before 2020 and in review studies, ethics committee approval is not required.
OUR JOURNAL POLICY ON ARTICLE SIMILARITY REPORT AND SIMILARITY RATIO
Candidate articles should be submitted with an originality report obtained from an academic plagiarism prevention programme (e.g. iThenticate, intihal.net, etc.). This rate is accepted up to 20%. Papers with a similarity rate above 20% will be returned at the preliminary control stage.
